Clinical Trial Update: A Safety, Pharmacokinetic and Efficacy Study of NUC-3373 in Combination With Standard Agents Used in Colorectal Cancer Treatment [Phase 1, Phase 2]

View source ↗

Summary

NuCana plc released results from an early-phase safety, pharmacokinetic, and efficacy study of NUC-3373 in combination with standard colorectal cancer therapies…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• NUC-3373

Snippet

Sponsor: NuCana plc | Conditions: Colorectal Cancer, Colorectal Neoplasms | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2025-04-23